337 related articles for article (PubMed ID: 26230769)
1. Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchis viverrini Endemic Settings in Thailand.
Saichua P; Yakovleva A; Kamamia C; Jariwala AR; Sithithaworn J; Sripa B; Brindley PJ; Laha T; Mairiang E; Pairojkul C; Khuntikeo N; Mulvenna J; Sithithaworn P; Bethony JM
PLoS Negl Trop Dis; 2015; 9(7):e0003949. PubMed ID: 26230769
[TBL] [Abstract][Full Text] [Related]
2. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
Wangboon C; Yongvanit P; Loilome W; Thanan R; Worasith C; Eamudomkarn C; Chamadol N; Mairiang E; Sithithaworn J; Saichua P; Sripa B; Khuntikeo N; Bethony JM; Sithithaworn P
Am J Trop Med Hyg; 2018 Jun; 98(6):1763-1769. PubMed ID: 29637887
[TBL] [Abstract][Full Text] [Related]
3. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
[No Abstract] [Full Text] [Related]
4. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG.
Wangboon C; Worasith C; Thanan R; Eamudomkarn C; Techasen A; Sithithaworn J; Loilome W; Chamadol N; Pinlaor S; Jumnainsong A; Yongvanit P; Khuntikeo N; Bethony JM; Sithithaworn P
Acta Trop; 2019 Jan; 189():124-128. PubMed ID: 30321522
[TBL] [Abstract][Full Text] [Related]
5. Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis.
Saichua P; Sithithaworn P; Jariwala AR; Diemert DJ; Sithithaworn J; Sripa B; Laha T; Mairiang E; Pairojkul C; Periago MV; Khuntikeo N; Mulvenna J; Bethony JM
PLoS Negl Trop Dis; 2013; 7(5):e2228. PubMed ID: 23717698
[TBL] [Abstract][Full Text] [Related]
6. High macrophage activities are associated with advanced periductal fibrosis in chronic Opisthorchis viverrini infection.
Salao K; Watakulsin K; Mairiang E; Suttiprapa S; Tangkawattana S; Edwards SW; Sripa B
Parasite Immunol; 2019 Jan; 41(1):e12603. PubMed ID: 30449026
[TBL] [Abstract][Full Text] [Related]
7. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis.
Thanan R; Murata M; Pinlaor S; Sithithaworn P; Khuntikeo N; Tangkanakul W; Hiraku Y; Oikawa S; Yongvanit P; Kawanishi S
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):518-24. PubMed ID: 18349269
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand.
Mairiang E; Laha T; Bethony JM; Thinkhamrop B; Kaewkes S; Sithithaworn P; Tesana S; Loukas A; Brindley PJ; Sripa B
Parasitol Int; 2012 Mar; 61(1):208-11. PubMed ID: 21771664
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of cagA+ Helicobacter pylori co-infected with Opisthorchis viverrini on hepatobiliary pathology in hamsters.
Suyapoh W; Tangkawattana S; Suttiprapa S; Punyapornwithaya V; Tangkawattana P; Sripa B
Acta Trop; 2021 Jan; 213():105740. PubMed ID: 33159904
[TBL] [Abstract][Full Text] [Related]
10. Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6.
Sripa B; Mairiang E; Thinkhamrop B; Laha T; Kaewkes S; Sithithaworn P; Tessana S; Loukas A; Brindley PJ; Bethony JM
Hepatology; 2009 Oct; 50(4):1273-81. PubMed ID: 19676135
[TBL] [Abstract][Full Text] [Related]
11. Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.
Thinkhamrop K; Khuntikeo N; Sithithaworn P; Thinkhamrop W; Wangdi K; Kelly MJ; Suwannatrai AT; Gray DJ
Infect Dis Poverty; 2019 Mar; 8(1):18. PubMed ID: 30890188
[TBL] [Abstract][Full Text] [Related]
12. Specific serum IgG, but not IgA, antibody against purified Opisthorchis viverrini antigen associated with hepatobiliary disease and cholangiocarcinoma.
Pinlaor P; Pongsamart P; Hongsrichan N; Sangka A; Srilunchang T; Mairiang E; Sithithaworn P; Pinlaor S
Parasitol Int; 2012 Mar; 61(1):212-6. PubMed ID: 21718798
[TBL] [Abstract][Full Text] [Related]
13. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
[TBL] [Abstract][Full Text] [Related]
14. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.
Rodpai R; Luvira V; Sadaow L; Sukeepaisarnjaroen W; Kitkhuandee A; Paonariang K; Sanpool O; Ittiprasert W; Mann VH; Intapan PM; Brindley PJ; Maleewong W
Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313
[TBL] [Abstract][Full Text] [Related]
15. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.
Chaiyarit P; Sithithaworn P; Thuwajit C; Yongvanit P
Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic values of parasite-specific antibody detections in saliva and urine in comparison with serum in opisthorchiasis.
Sawangsoda P; Sithithaworn J; Tesana S; Pinlaor S; Boonmars T; Mairiang E; Yongvanit P; Duenngai K; Sithithaworn P
Parasitol Int; 2012 Mar; 61(1):196-202. PubMed ID: 21704727
[TBL] [Abstract][Full Text] [Related]
17. Current high prevalences of Strongyloides stercoralis and Opisthorchis viverrini infections in rural communities in northeast Thailand and associated risk factors.
Laoraksawong P; Sanpool O; Rodpai R; Thanchomnang T; Kanarkard W; Maleewong W; Kraiklang R; Intapan PM
BMC Public Health; 2018 Jul; 18(1):940. PubMed ID: 30064407
[TBL] [Abstract][Full Text] [Related]
18. Subtle to severe hepatobiliary morbidity in Opisthorchis viverrini endemic settings in southern Laos.
Ayé Soukhathammavong P; Rajpho V; Phongluxa K; Vonghachack Y; Hattendorf J; Hongvanthong B; Rasaphon O; Sripa B; Akkhavong K; Hatz C; Odermatt P
Acta Trop; 2015 Jan; 141(Pt B):303-9. PubMed ID: 25275346
[TBL] [Abstract][Full Text] [Related]
19. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
Buisson Y
Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini.
Sripa B; Thinkhamrop B; Mairiang E; Laha T; Kaewkes S; Sithithaworn P; Periago MV; Bhudhisawasdi V; Yonglitthipagon P; Mulvenna J; Brindley PJ; Loukas A; Bethony JM
PLoS Negl Trop Dis; 2012; 6(5):e1654. PubMed ID: 22629477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
